JPRN-UMIN000018986已完成未知
Examination of usefulness and safety of heparinoid agent based external medicine (over counter drug) for facial dryness symptom. - Usefulness of heparinoid agent based external medicine for facial dryness symptom.
Osaka city university graduate school of medicine, department of dermatology0 个研究点目标入组 50 人开始时间: 2015年9月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 35years-old 至 65years-old(—)
- 性别
- Female
入选标准
- 未提供
排除标准
- •The person 1. Who takes in an oral pharmaceutical product or a supplement which may affect the skin condition habitually. 2. Who had the anamnestic history of surgical operation on the testing area. 3. Who is infected with hemorrhagic disease. 4. Who has skin rash of atopic dermatitis on face. 5. Who uses regularly an external medicine. 6. Who had the anamnesis of heparinoid allergy. 7. Who has allergy or sensitivity to drug and cosmetics. 8. Who can not agree that using same cosmetics all over the study time. 9. Who has skin disease on the testing area. 10. Who has the factor on the testing area which may affect the result. 11. Who has critical illness of glucose metabolism, lipid metabolism, liver function, renal function, cardiovascular system, respiratory tract, endocrine system, immune system and nervous system, or had the anamnestic history of psychiatric disorder. 12. Who can not understand about examination contents. 13. Who is pregnant or lactating. 14. Who is impossible to come to the testing institution on an examination day. 15. Who participates in other examinations. 16. Who is recognized to be inappropriate as a subject by attending physician.
研究者
相似试验
已完成
不适用
sefulness of topical heparinoid in the treatment of asteatosis in hemodialyzed patientsasteatosis in hemodialyzed patientJPRN-UMIN000029360ippon medical school hospital76
已完成
2 期
Heparin administration in coronary angiographyAtherosclerotic heart disease.Atherosclerotic heart diseaseIRCT201202199080N1Hamadan university of medical sciences500
已完成
不适用
Effect OF Heparin solution for prevention of pain and swelling at the site of peripheral intravenous catheter.CTRI/2017/10/010089PARUL INSTITUTE OF MEDICAL SCIENCE AND RESEARCH100
尚未招募
2 期
The Evaluation of effectiveness of heparin nebulizer in reduction of respiratory distress in patients with COVID-19COVID-19.COVID-19, virus identifiedU07.1IRCT20210513051275N1Islamic Azad University60
尚未招募
1 期
A trial to assess the safety of nebulised heparin for acute lung injuryAcute lung injuryRespiratory - Other injuries and accidentsACTRN12606000388516St Vincents Health Melboune20
